Antistreptococcal treatment of guttate psoriasis: A controlled study

International Journal of Dermatology

Volumn 47, Issue 9, 2008, Pages 950-952

  Dogan, Bilal ^a,b   Karabudak, Ozlem ^a   Harmanyeri, Yavuz ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; PENICILLIN V;

ADULT; ARTICLE; BETA HEMOLYTIC STREPTOCOCCUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FOLLOW UP; HUMAN; MALE; OUTCOME ASSESSMENT; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEROLOGY; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS INFECTION; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ERYTHROMYCIN; FOLLOW-UP STUDIES; HUMANS; MALE; PENICILLIN V; PROBABILITY; PSORIASIS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STREPTOCOCCAL INFECTIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 50149109002     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03663.x     Document Type: Article

References (12)

1. Griffiths CEM, Camp RDR, Barker JNWN. Psoriasis. In: Burns T, Breathnach S, Cox N, et al. eds. Rook's Textbook of Dermatology, 7th edn. Oxford: Blackwell Science, 2004, 35, 11.
2. Martin BA, Chalmers RJ, Telfer NR. How great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Arch Dermatol 1996; 132: 717-718.
3. Christophers E, Mrowietz U. Psoriasis. In: Freedberg IM, Eisen AZ, Wolff K, et al. eds. Fitzpatrick's Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, 1999: 503.
4. Vincent F, Ross JB, Dalton M, et al. A therapeutic trial of the use of penicillin V or erythromycine with or without rifampin in the treatment of psoriasis. J Am Acad Dermatol 1992; 26: 458-461.
5. Valdimarsson H, Baker BS, Jonsdottir I, et al. Psoriasis: A T-cell mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1996; 17: 46-47.
6. Telfer NR, Chalmers RJ, Whale K, et al. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 1992; 128: 39-42.
7. Baker BS, Bokth S, Powles A, et al. Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions. Br J Dermatol 1993; 128: 493-499.
8. Owen CM, Chalmers RJG, O'Sullivan T, et al. A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol 2001; 145: 886-890.
9. Tsankov N, Grozdev I, Kkzandjieva J. Old drug-new indication. Rifampicin in psoriasis. J Dermatolog Treat 2006; 17: 18-23.
10. Caca-Biljanovska NG, V'lckova-Laskoska MT. Management of guttate and generalized psoriasis vulgaris: Prospective randomized study. Croat Med J 2002; 43: 707-712.
11. Rosenberg EW, Noah PW, Skinner RB Jr. Microorganisms and psoriasis. J Natl Med Assoc 1994; 86: 305-310.
12. Rosenberg EW, Noah PW, Whatt RJ, et al. Complement activation in psoriasis. Clin Exp Dermatol 1990; 15: 16-20.